← Back to Clinical Trials
Recruiting NCT05522647

NCT05522647 Detection of Risk Behaviors: Pilot Observational Study With Bedridden and Agitated Patients.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05522647
Status Recruiting
Phase —
Sponsor University Hospital, Clermont-Ferrand
Condition Risk Behavior
Study Type OBSERVATIONAL
Enrollment 20 participants
Start Date 2025-07-09
Primary Completion 2026-07-09

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 20 participants in total. It began in 2025-07-09 with a primary completion date of 2026-07-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

There is a risk of falls and injuries in bedridden hospitalized patients, increased in agitated or confused patients. In neurosurgery departments, brain damaged patients can present a loss of consciousness of risky behaviors and be in a state of agitation which frequently leads to their endangerment. The repercussions of this endangerment are multiple. For the patients, there may be a feeling of insecurity, with physical or chemical restraint solutions which deprive them of their freedom without a total guarantee of safety. For the caregivers, there is an emotional distress in front of this endangerment, and a professional guilt. Finally, there are economic repercussions due to the costs of complementary examinations and the lengthening of hospitalization. The objective of the present study is to determine the nature and frequency of occurrence of risk behaviours, through the observation of bedridden and agitated hospitalized patients. These risk behaviours are defined as potentially dangerous and are warning signs for the caregiver. A better understanding of these behaviours could help to better anticipate falls and injuries and to implement preventive measures more quickly.

Eligibility Criteria

Inclusion Criteria: * Hospitalized in the Neurosurgery Department of the Clermont-Ferrand University Hospital * Suffering from neurological and/or cognitive disorders leading to agitation and/or confusion * Affiliation to a social security system * Hospitalization in the department for at least 9 days * Acceptance by the patient and/or trusted person capable of giving informed consent to participate in the research Exclusion Criteria: * Acute or transient agitation phase of somatic origin (bladder globe, pain, ionic disorder...) * Patient under guardianship, curatorship or safeguard of justice * Pregnant and breastfeeding women * Refusal to participate

Contact & Investigator

Central Contact

Lise Laclautre

✉ promo_interne_drci@chu-clermontferrand.fr

📞 334.73.754.963

Principal Investigator

Charlène DUBOIS

PRINCIPAL INVESTIGATOR

University Hospital, Clermont-Ferrand

Frequently Asked Questions

Who can join the NCT05522647 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Risk Behavior. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05522647 currently recruiting?

Yes, NCT05522647 is actively recruiting participants. Contact the research team at promo_interne_drci@chu-clermontferrand.fr for enrollment information.

Where is the NCT05522647 trial being conducted?

This trial is being conducted at Clermont-Ferrand, France.

Who is sponsoring the NCT05522647 clinical trial?

NCT05522647 is sponsored by University Hospital, Clermont-Ferrand. The principal investigator is Charlène DUBOIS at University Hospital, Clermont-Ferrand. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology